NCT03930225

Brief Summary

randomized controlled study measuring the effectiveness of Stigma focused intervention in patients suffering from Schizophrenia

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable schizophrenia

Timeline
Completed

Started Apr 2019

Longer than P75 for not_applicable schizophrenia

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 16, 2019

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

April 24, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 29, 2019

Completed
5.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 2, 2024

Completed
Last Updated

July 10, 2025

Status Verified

July 1, 2025

Enrollment Period

5.2 years

First QC Date

April 24, 2019

Last Update Submit

July 6, 2025

Conditions

Keywords

StigmaIntervention programSchizophrenia

Outcome Measures

Primary Outcomes (3)

  • change in Self-Stigma using the Arabic version of the internalized stigma of mental illness scale

    stigma as experienced by patients themselves

    Baseline assessment followed by Point 1 Assessment at the end of the 8 weekly sessions of the program ( after 2 months from baseline assessment) Final assessment after 3 months from point 1 Assessment

  • change in perceived family burden using the perceived family burden scale

    how much the disorder represent a burden on family

    Baseline assessment---- followed by Point 1 Assessment at the end of the 8 weekly sessions of the program ( after 2 months from baseline assessment) Final assessment after 3 months from point 1 Assessment

  • change in medication adherence using customized chart for each patient

    the degree the patient adhere to the prescribed medications

    Baseline assessment followed by Point 1 Assessment at the end of the 8 weekly sessions of the program ( after 2 months from baseline assessment) fFinal assessment after 3 months from point 1 Assessment

Secondary Outcomes (1)

  • change in the clinical outcome using Positive and Negative Symptoms Scale

    Baseline assessment followed by Point 1 Assessment at the end of the 8 weekly sessions of the program ( after 2 months from baseline assessment) Final assessment after 3 months from point 1 Assessment

Study Arms (2)

study group

EXPERIMENTAL

In the study group, both patients and their family members will be required to attend a weekly 1 hour long psycho-educational sessions. Moreover assessment sessions will be attended also. "The stigma directed intervention program"

Behavioral: Stigma Directed Psycho-educational Intervention program

control group

OTHER

In the control group, only Patients will attend the psycho-educational sessions. Family members and patients will be required to attend the assessment sessions.

Behavioral: Stigma Directed Psycho-educational Intervention program

Interventions

psycho-educational intervention with emphasis on Stigma

control groupstudy group

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patients meet the diagnosis of schizophrenia or schizoaffective disorder according to DSM5.The clinical condition is stabilized.
  • Age range between 18 to 50 years.
  • Male and female sexes are included.
  • Availability of close relative in direct contact with the patient.
  • Primary caregiver and the family member share household with patient.
  • No history of receiving treatment of psychiatric disorders.
  • No history of serious head trauma.

You may not qualify if:

  • Co morbid substance abuse or dependence disorder.
  • Co morbid intellectual disability.
  • Co morbid chronic medical or neurological condition or history of serious head trauma.
  • Sever physical illness that hinders their participation- -

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mansoura University Psychiatry Department

Al Mansurah, Dakahlya, Egypt

Location

MeSH Terms

Conditions

SchizophreniaSocial Stigma

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental DisordersSocial BehaviorBehavior

Study Officials

  • Vishwaijt Nimgaonkar, PhD

    Pittsburgh university

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
the outcome will be assessed by a different personnel than the investigator conducting the sessions of the intervention. The outcomes assessor will be blinded to which arm each participant belongs.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Randomized Controlled Study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Local Principal Investigator

Study Record Dates

First Submitted

April 24, 2019

First Posted

April 29, 2019

Study Start

April 16, 2019

Primary Completion

June 30, 2024

Study Completion

November 2, 2024

Last Updated

July 10, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations